POWERED BY LEXARIA BIOSCIENCE
LIVE

Serial Number

88624762

Owner

Lexaria Bioscience Corp.

First Use Date

Jul 31, 2019

Filing Date

Sep 20, 2019

Add to watchlist:

No watchlists yet
View on USPTO

POWERED BY LEXARIA BIOSCIENCE Trademark

Serial Number: 88624762 • Registration: 7718128

POWERED BY LEXARIA BIOSCIENCE is a trademark filed by Lexaria Bioscience Corp. on September 20, 2019. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services), Class 30 (Staple Foods), Class 32 (Light Beverages), Class 33 (Wine & Spirits). The application is currently registered and active.

Owner Contact Info

Lexaria Bioscience Corp. (7 trademarks)

Phoenix, AZ 85021

Entity Type: 03

Trademark Details

Filing Date

September 20, 2019

Registration Date

March 11, 2025

First Use Anywhere

July 31, 2019

First Use in Commerce

July 31, 2019

Published for Opposition

February 20, 2024

Goods & Services

(Based on 44(e)) Chocolates, chocolate confections and candy, puddings, custards; non-alcoholic beverages, namely, coffee, coffee-based beverages, tea, cocoa-based beverages; beverage flavourings, namely, syrup for flavouring beverages; honey; salad dressings; snack food products, namely, granola-based snack bars, cereal-based energy bars, chocolate-based energy bars, chocolatebased meal replacement bars, crackers and cookies; flour and preparations made from cereals, namely, breads and pastries; condiments, namely, dipping sauce and marinades; seasonings

(Based on Use in Commerce) (Based on 44(e)) Dietary, nutritional and herbal supplements and vitamins for general physical health and mental well-being for consumption by humans in swallowable, edible or drinkable form; dietary, nutritional and herbal supplements and vitamins for general physical health and mental well-being for consumption by animals in swallowable, edible or drinkable form; pharmaceutical preparations for the treatment of epilepsy, erectile dysfunction, glaucoma, high blood pressure, anxiety, nausea, nicotine addiction, drug addiction, alcohol addiction, gambling addiction, eating disorders, namely, bulimia nervosa, anorexia, obesity and hypothyroidism, migraines, headaches, joint pain, nerve pain, multiple sclerosis, inflammation, insomnia, acne, diabetes, schizophrenia, cancer, menopause, premenstrual syndrome, heart conditions, blood clots, incontinence, hormonal imbalance, high or low thyroid conditions, viral diseases, namely, colds, flus, herpes, hepatitis, human immunodeficiency viruses and acquired immune deficiency syndrome, sinus congestion, allergies, baldness, thinning hair, sexual stamina, dental and oral diseases, neurological disorders, namely, cerebral palsy, Huntington's Disease, Alzheimer's and Parkinson's Disease; veterinary pharmaceutical preparations for the treatment of periodontal diseases, respiratory and reproductive diseases, arthritis, muscle soreness and sprains, bacterial infections, infectious diseases, namely, respiratory infections, eye infections, topical infections, swine dysentery, bacterial enteritis, Bluecomb and pneumonia, nutritional muscular dystrophy, parasites, vitamin deficiencies and udder care; medicated topical creams, lotions, gels, balms, oils and ointments for human use for lip and skin dryness, cold sores, burns, hives and skin diseases, namely, rosacea, eczema, psoriasis and warts, all of the aforesaid excluding products, preparations and substances for the prevention and treatment of depression or psychosis

(Based on 44(e)) Cosmetics, namely, skin creams, skin lotions, face and body washes, and under eye treatments in the nature of beauty serums; sunscreen creams; skin lightening creams; skin moisturizers; skin care products, namely, non-medicated skin serum; non- medicated foot creams; skin toners; astringents for cosmetic purposes; non-medicated lip care preparations

(Based on Use in Commerce) (Based on 44(e)) Licensing of intellectual property, namely, licensing patents and trademarks to third parties for the purposes of enhancing taste, smell and bioabsorption of third party goods for the benefit of the consumer

(Based on 44(e)) Wine; spirits, namely, vodka, rum, gin, distilled blue agave liquor, whiskey and brandy; prepared alcoholic cocktails and alcoholic cocktail mixes

(Based on 44(e)) Beer; non-alcoholic beverages, namely, energy drinks, infused drinking water, fruit beverages and carbonated soft drinks; syrups for beverages; powder for making beverages, namely, powder drink crystals

(Based on 44(e)) Biochemical research and analysis services, namely, research associated with hepatic and lymphatic transport of bioactive molecules

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 11, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Mar 11, 2025 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Feb 19, 2025 DP1B
NOTICE OF ALLOWANCE CANCELLED
Oct 8, 2024 IUCN
TEAS DELETE 1(B) BASIS RECEIVED
Oct 8, 2024 D1BR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 8, 2024 NOAM
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Aug 29, 2024 ETOP
POST PUBLICATION AMENDMENT - ENTERED
Aug 15, 2024 CHPB
ASSIGNED TO PETITION STAFF
Aug 13, 2024 APET
TEAS POST PUBLICATION AMENDMENT RECEIVED
Jul 23, 2024 EPPA
EXTENSION OF TIME TO OPPOSE RECEIVED
Mar 15, 2024 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 4, 2024 NPUB
PUBLISHED FOR OPPOSITION
Feb 20, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 1, 2024 NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 1, 2024 NONP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 1, 2024 NPUB
ELECTRONIC RECORD REVIEW COMPLETE
Jan 16, 2024 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Jan 12, 2024 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 16, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 12, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 12, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 12, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 11, 2023 GNRN
NON-FINAL ACTION E-MAILED
Sep 11, 2023 GNRT
NON-FINAL ACTION WRITTEN
Sep 11, 2023 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jul 21, 2023 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Jul 4, 2023 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 20, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 12, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 12, 2023 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
May 11, 2023 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 10, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 10, 2023 GNSL
SUSPENSION LETTER WRITTEN
Feb 10, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 13, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 13, 2023 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jan 12, 2023 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jan 12, 2023 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jan 12, 2023 GNSI
SUSPENSION INQUIRY WRITTEN
Jan 12, 2023 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 7, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Jul 7, 2022 GNSL
SUSPENSION LETTER WRITTEN
Jul 7, 2022 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 7, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 7, 2022 CRFA
ASSIGNED TO LIE
Jul 7, 2022 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jul 6, 2022 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jul 5, 2022 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jul 5, 2022 GNSI
SUSPENSION INQUIRY WRITTEN
Jul 5, 2022 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jun 24, 2022 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 4, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
Dec 4, 2021 GNSL
SUSPENSION LETTER WRITTEN
Dec 4, 2021 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 2, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 2, 2021 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Oct 26, 2021 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Oct 26, 2021 GNS2
INQUIRY TO SUSPENSION E-MAILED
Oct 26, 2021 GNSI
SUSPENSION INQUIRY WRITTEN
Oct 26, 2021 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Sep 20, 2021 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 24, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 24, 2021 GNSL
SUSPENSION LETTER WRITTEN
Feb 24, 2021 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 23, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 23, 2021 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Feb 18, 2021 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sep 2, 2020 GNS3
LETTER OF SUSPENSION E-MAILED
Sep 2, 2020 GNSL
SUSPENSION LETTER WRITTEN
Sep 2, 2020 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 12, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 12, 2020 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Aug 7, 2020 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 14, 2020 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 14, 2020 GNSL
SUSPENSION LETTER WRITTEN
Feb 14, 2020 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 11, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 10, 2020 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jan 10, 2020 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jan 7, 2020 GNS3
LETTER OF SUSPENSION E-MAILED
Jan 7, 2020 GNSL
SUSPENSION LETTER WRITTEN
Jan 7, 2020 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 6, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 6, 2019 CRFA
ASSIGNED TO LIE
Nov 27, 2019 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 21, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 19, 2019 GNRN
NON-FINAL ACTION E-MAILED
Nov 19, 2019 GNRT
NON-FINAL ACTION WRITTEN
Nov 19, 2019 CNRT
ASSIGNED TO EXAMINER
Nov 12, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 26, 2019 NWOS
NEW APPLICATION ENTERED
Sep 24, 2019 NWAP